|
|
Article: Euro life science industry under pressure; EU enlargement hopes.(European Union)
- Article from:
- Pharma Marketletter
- Article date:
- April 5, 2004
CopyrightCOPYRIGHT 2004 Marketletter Publications Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Although Europe may lead the world in pharmaceutical manufacturing, it trails behind when it comes to innovation in life sciences. European success is hindered by a fragmented market, intense pressure to lower manufacturing and R&D costs and a climate that fails to encourage or reward innovation, according to a new report from Cap Gemini Ernst & Young.
However, the addition of 10 new countries as part of the European Union's enlargement this year has the potential to strengthen Europe's position in the life sciences sector in the long term. It will provide access to a wider pool of skills, a larger reservoir of patients for clinical trials and more cost-effective ...